跳至主要内容
临床试验/IRCT2015022821269N1
IRCT2015022821269N1已完成2 期

Pain relieving effect of intra-operative chemical splanchnicectomy of celiac ganglions in patients with resectable pancreatic or gastric masses: a randomized clinical trial

Vice chancellor for research, Iran University of Medical Sciences0 个研究点目标入组 44 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
44

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
15 years 至 80 years(—)
性别
All

入选标准

  • Resectable pancreatic cancer or gastric cancer; Obtaining informed consent for probable alcohol injection during surgery.
  • Exclusion criteria: Unresectable pancreatic cancer; Unresectable gastric cancer; Patients those who underwent neo-adjuvant chemotherapy; Patients who dissatisfaction with the procedures; Patients who expires before 4 month after operation; Prolonged post-operation hospitalization (more than 15 days) due to surgical complications; Age less than 15 or more than 80 year; History of prolonged consumption of opioids, NSAIDS, analgesic and anti-depressant drugs; Cardiac or pulmonary diseases; Sensitivity to opioid drugs; Psychological disorders; Abnormal arterial blood gas analysis; Happening of surgical complications or any other signs that results in disability to complete pain scale questionnaire (such as loss of consciousness).

排除标准

  • 未提供

研究者

发起方
Vice chancellor for research, Iran University of Medical Sciences

相似试验